{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T20:42:35Z","timestamp":1781210555976,"version":"3.54.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T00:00:00Z","timestamp":1536451200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the Key Programs of Medical Science and Technology Development Foundation of the Nanjing Department of Health","award":["QRX11026"],"award-info":[{"award-number":["QRX11026"]}]},{"name":"Science and Technology Development Foundation of Nanjing Medical University","award":["2014NJMU047"],"award-info":[{"award-number":["2014NJMU047"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s10067-018-4283-z","type":"journal-article","created":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T19:57:36Z","timestamp":1536436656000},"page":"3107-3113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Febuxostat in the treatment of gout patients with low serum uric acid level: 1-year finding of efficacy and safety study"],"prefix":"10.1007","volume":"37","author":[{"given":"Minning","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjie","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijie","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinglei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6623-7703","authenticated-orcid":false,"given":"Xingguo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,9]]},"reference":[{"key":"4283_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/SMJ.0000000000000082","volume":"107","author":"E Karis","year":"2014","unstructured":"Karis E, Crittenden DB, Pillinger MH (2014) Hyperuricemia, gout, and related comorbidities: cause and effect on a two-way street. South Med J 107:235\u2013241","journal-title":"South Med J"},{"key":"4283_CR2","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1002\/art.39254","volume":"67","author":"T Neogi","year":"2015","unstructured":"Neogi T, Jansen TLTA, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJEM, Liot\u00e9 F, Naden RP, Nuki G, Ogdie A, Perez-Ruiz F, Saag K, Singh JA, Sundy JS, Tausche AK, Vaquez-Mellado J, Yarows SA, Taylor WJ (2015) 2015 gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 67:2557\u20132568","journal-title":"Arthritis Rheum"},{"key":"4283_CR3","doi-asserted-by":"crossref","unstructured":"Richette P, Doherty M, Pascual E et al (2017) 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis 76(1):29\u201342","DOI":"10.1136\/annrheumdis-2016-209707"},{"key":"4283_CR4","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s10067-014-2725-9","volume":"34","author":"D Shi","year":"2015","unstructured":"Shi D, Xu J-X, Wu H-X, Wang Y, Zhou QJ, Yu RS (2015) Methods of assessment of tophus and bone erosions in gout using dual-energy CT: reproducibility analysis. Clin Rheumatol 34:755\u2013765","journal-title":"Clin Rheumatol"},{"key":"4283_CR5","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1093\/rheumatology\/keq204","volume":"49","author":"B lvarez-Lario","year":"2010","unstructured":"lvarez-Lario B, Macarr\u00f3n-Vicente J (2010) Uric acid and evolution. Rheumatology 49:2010\u20132015","journal-title":"Rheumatology"},{"key":"4283_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1006\/abbi.2000.1721","volume":"376","author":"GL Squadrito","year":"2000","unstructured":"Squadrito GL, Cueto R, Splenser AE, Valavanidis A, Zhang H, Uppu RM, Pryor WA (2000) Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid. Arch Biochem Biophys 376:333\u2013337","journal-title":"Arch Biochem Biophys"},{"key":"4283_CR7","unstructured":"Decker J (1966) Report from the subcommittee on diagnostic criteria for gout. In: Population studies of the rheumatic diseases. Proceedings of the Third International Symposium, New York. p 385\u2013387"},{"key":"4283_CR8","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/art.1780200320","volume":"20","author":"SL Wallace","year":"1977","unstructured":"Wallace SL, Robinson H, Masi AT, Decker JL, Mccarty DJ, Y\u00fc T'F (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20:895\u2013900","journal-title":"Arthritis Rheum"},{"key":"4283_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1136\/ard.23.1.81-b","volume":"23","author":"J Lawrence","year":"1964","unstructured":"Lawrence J (1964) The epidemiology of chronic rheumatism. Ann Rheum Dis 23:81\u201382","journal-title":"Ann Rheum Dis"},{"key":"4283_CR10","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1001\/archinternmed.2010.196","volume":"170","author":"HJ Janssens","year":"2010","unstructured":"Janssens HJ, Fransen J, Van De Lisdonk EH et al (2010) A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis. Arch Intern Med 170:1120\u20131126","journal-title":"Arch Intern Med"},{"key":"4283_CR11","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.clinimag.2014.12.015","volume":"39","author":"H-J Hu","year":"2015","unstructured":"Hu H-J, Liao M-Y, Xu L-Y (2015) Clinical utility of dual-energy CT for gout diagnosis. Clin Imaging 39:880\u2013885","journal-title":"Clin Imaging"},{"key":"4283_CR12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s40265-015-0360-7","volume":"75","author":"JE Frampton","year":"2015","unstructured":"Frampton JE (2015) Febuxostat: a review of its use in the treatment of hyperuricaemia in patients with gout. Drugs 75:427\u2013438","journal-title":"Drugs"},{"key":"4283_CR13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/annrheumdis-2013-203779","volume":"74","author":"P Richette","year":"2015","unstructured":"Richette P, Clerson P, P\u00e9rissin L, Flipo RM, Bardin T (2015) Revisiting comorbidities in gout: a cluster analysis. Ann Rheum Dis 74:142\u2013147","journal-title":"Ann Rheum Dis"},{"key":"4283_CR14","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3346\/jkms.2014.29.5.657","volume":"29","author":"K Joo","year":"2014","unstructured":"Joo K, Kwon S-R, Lim M-J, Jung KH, Joo H, Park W (2014) Prevention of comorbidity and acute attack of gout by uric acid lowering therapy. J Korean Med Sci 29:657\u2013661","journal-title":"J Korean Med Sci"},{"key":"4283_CR15","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12916-016-0732-1","volume":"14","author":"JA Singh","year":"2016","unstructured":"Singh JA (2016) Gout: will the \u201cKing of Diseases\u201d be the first rheumatic disease to be cured? BMC Med 14:180","journal-title":"BMC Med"},{"key":"4283_CR16","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00296-012-2442-0","volume":"33","author":"MA \u00d6zt\u00fcrk","year":"2013","unstructured":"\u00d6zt\u00fcrk MA, Kaya A, \u015eenel S et al (2013) Demographic and clinical features of gout patients in Turkey: a multicenter study. Rheumatol Int 33:847\u2013852","journal-title":"Rheumatol Int"},{"key":"4283_CR17","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1093\/rheumatology\/kev030","volume":"54","author":"B Spaetgens","year":"2015","unstructured":"Spaetgens B, Wijnands JM, Van Durme C et al (2015) Content and construct validity of the rheumatic diseases comorbidity index in patients with gout. Rheumatology 54:1659\u20131663","journal-title":"Rheumatology"},{"key":"4283_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s10495-014-1057-1","volume":"20","author":"JY Choe","year":"2015","unstructured":"Choe JY, Park KY, Kim SK (2015) Oxidative stress by monosodium urate crystals promotes renal cell apoptosis through mitochondrial caspase-dependent pathway in human embryonic kidney 293 cells: mechanism for urate-induced nephropathy. Apoptosis 20:38\u201349","journal-title":"Apoptosis"},{"key":"4283_CR19","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/ndt\/gft248","volume":"29","author":"SR Mulay","year":"2014","unstructured":"Mulay SR, Evan A, Anders HJ (2014) Molecular mechanisms of crystal-related kidney inflammation and injury. Implications for cholesterol embolism, crystalline nephropathies and kidney stone disease. Nephrol Dial Transplant 29:507\u2013514","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"4283_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13075-015-0610-9","volume":"17","author":"MJ Roughley","year":"2015","unstructured":"Roughley MJ, Belcher J, Mallen CD, Roddy E (2015) Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies. Arthritis Res Ther 17(1):90","journal-title":"Arthritis Res Ther"},{"key":"4283_CR21","first-page":"1950","volume":"29","author":"W Urano","year":"2002","unstructured":"Urano W, Yamanaka H, Tsutani H, Nakajima H, Matsuda Y, Taniguchi A, Hara M, Kamatani N (2002) The inflammatory process in the mechanism of decreased serum uric acid concentrations during acute gouty arthritis. J Rheumatol 29:1950\u20131953","journal-title":"J Rheumatol"},{"key":"4283_CR22","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1136\/annrheumdis-2013-204273","volume":"74","author":"N Dalbeth","year":"2015","unstructured":"Dalbeth N, Aati O, Kalluru R, Gamble GD, Horne A, Doyle AJ, McQueen FM (2015) Relationship between structural joint damage and urate deposition in gout: a plain radiography and dual-energy CT study. Ann Rheum Dis 74:1030\u20131036","journal-title":"Ann Rheum Dis"},{"key":"4283_CR23","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/rheumatology\/ken457","volume":"48","author":"H Schumacher Jr","year":"2009","unstructured":"Schumacher H Jr, Becker M, Lloyd E et al (2009) Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study. Rheumatology 48:188\u2013194","journal-title":"Rheumatology"},{"key":"4283_CR24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1080\/15257770802136032","volume":"27","author":"MA Becker","year":"2008","unstructured":"Becker MA, Macdonald PA, Hunt BJ et al (2008) Determinants of the clinical outcomes of gout during the first year of urate-lowering therapy. Nucleosides Nucleotides Nucleic Acids 27:585\u2013591","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"4283_CR25","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/hr.2014.107","volume":"37","author":"Y Shibagaki","year":"2014","unstructured":"Shibagaki Y, Ohno I, Hosoya T, Kimura K (2014) Safety, efficacy and renal effect of febuxostat in patients with moderate-to-severe kidney dysfunction. Hypertens Res 37:919\u2013925","journal-title":"Hypertens Res"},{"key":"4283_CR26","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3899\/jrheum.080814","volume":"36","author":"MA Becker","year":"2009","unstructured":"Becker MA, Schumacher HR, Macdonald PA et al (2009) Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout. J Rheumatol 36:1273\u20131282","journal-title":"J Rheumatol"},{"key":"4283_CR27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000434633","volume":"96","author":"D Hira","year":"2015","unstructured":"Hira D, Chisaki Y, Noda S, Araki H, Uzu T, Maegawa H, Yano Y, Morita SY, Terada T (2015) Population pharmacokinetics and therapeutic efficacy of febuxostat in patients with severe renal impairment. Pharmacology 96:90\u201398","journal-title":"Pharmacology"},{"key":"4283_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10067-014-2806-9","volume":"35","author":"L Ma","year":"2016","unstructured":"Ma L, Wei L, Chen H, Zhang Z, Yu Q, Ji Z, Jiang L (2016) Influence of urate-lowering therapies on renal handling of uric acid. Clin Rheumatol 35:133\u2013141","journal-title":"Clin Rheumatol"},{"key":"4283_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/1529-0131(200001)43:1<103::AID-ANR13>3.0.CO;2-C","volume":"43","author":"D Caspi","year":"2000","unstructured":"Caspi D, Lubart E, Graff E et al (2000) The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheumatol 43:103\u2013108","journal-title":"Arthritis Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-4283-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4283-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4283-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T19:03:31Z","timestamp":1567969411000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-4283-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,9]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["4283"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-4283-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,9]]},"assertion":[{"value":"1 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}